跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 58,469 条关于
“MajesTEC-1”
全部
58,469
临床试验
34,711
药物
7,245
机构
1,383
资讯
15,130
去年
Teclistamab Shows Sustained Efficacy in Relapsed/Refractory Multiple Myeloma
4年前
Teclistamab Shows Promise in Heavily Pretreated Multiple Myeloma
2年前
NHS Scotland Approves Elranatamab and Teclistamab for Relapsed/Refractory Multiple Myeloma
4年前
Bispecific Antibodies Teclistamab and Talquetamab Show Promise in Multiple Myeloma Treatment
2年前
Real-World Teclistamab Data Shows Comparable Efficacy to Clinical Trials Despite Higher Toxicity Rates in Multiple Myeloma
去年
Teclistamab Shows Promising Results in Chinese Patients with Relapsed/Refractory Multiple Myeloma
去年
GPRC5D Emerges as Promising Target in Multiple Myeloma Clinical Trials
4年前
Teclistamab-Daratumumab Combination Shows Promising Results in Heavily Pretreated Multiple Myeloma Patients
去年
Teclistamab Maintenance Therapy Shows Promise in Newly Diagnosed Multiple Myeloma
去年
Teclistamab Shows Promise as Frontline Therapy for Multiple Myeloma in Newly Diagnosed Patients
第 1 页,共 1513 页
上一页
下一页